Published in Primary Care

Welcome to Inside Intrepid

This is editorially independent content

Apr 14, 2026

Eyes On Eyecare is thrilled to announce our newest channel, Inside Intrepid, featuring dynamic discussions from members of the Intrepid Eye Society.

Welcome to Inside Intrepid from Eyes On Eyecare Vimeo on Vimeo

Founded in 2015, the Intrepid Eye Society (IES) is a collective of trusted innovators and emerging thought leaders shaping the future of optometry.

Insights into Intrepid Eye Society

Members are distributed across the United States and Canada, contributing to both local communities and the broader optometric landscape. Intrepid members demonstrate significant impact across the profession, delivering over 1,600 hours of continuing education and presenting at more than 250 organizations in 2025 alone.

Intrepid Eye Society supports professional development through a range of educational initiatives, including webinars, panels, workshops, and roundtables. Signature offerings, such as advisory boards, the annual Innovation Summit Conference, and New Technology Summits, provide opportunities for continuing education, networking, and engagement with cutting-edge technologies. These efforts foster meaningful collaboration between clinicians and industry leaders.

About Inside Intrepid

Built for the busy clinician, the Inside Intrepid blends clinical insight, candid debate, and forward-looking perspective—highlighting how optometry’s leaders think, challenge convention, and advance patient care.

Each episode will feature two to three IES members in a candid, 15-minute peer-to-peer conversation exploring the challenges and innovations shaping modern optometry.

Over the course of 2026, we will be covering a wide variety of relevant topics, including (but not limited to):

Don’t miss an episode

The members of Intrepid Eye Society will be offering the freshest eyecare education bi-monthly. Watch the first episode Redefining Optometry's Role in Surgical Collaboration now!

Dr. Lang received his Doctor of Optometry degree from The New England College of Optometry in Boston, MA. He writes articles for several publications and is actively involved in lecturing to colleagues at various meetings locally and nationally.

This article was written by Sonia Kelley, OD, MS, based on the recorded video from Drs. Schaeffer and Pribis.

Key takeaways

  • Examination of the retina is advised in all patients prior to initiation of therapy with pilocarpine for presbyopia.
  • Both labels carry warnings regarding rare retinal detachment with miotics. Both note increased risk in patients with pre-existing retinal disease.
  • Dr. Pribis does not prescribe pilocarpine to patients with axial length greater than 26.5mm or more than 6.00D of myopia, and considers history of refractive surgery in that calculation.
  • Proactive counseling on common adverse events, including burning, dimming, and headache, may help reduce post-instillation patient calls, according to Dr. Pribis' experience.